Figure 5From: Renoprotective capacities of non-erythropoietic EPO derivative, ARA290, following renal ischemia/reperfusion injuryThe effect of ARA290 on Kim-1 mRNA expression. Early ARA290 treatment reduced Kim-1 expression at three days post-reperfusion indicating reduced acute kidney injury (p < 0.05). Late- or repetitive treatment did not reduce Kim-1 mRNA expression.Back to article page